Peter Kropp

Dr. Peter Kropp

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2008 in Der Schmerz
Verified
Journal Article
Closed access
PDF file
ASAndreas Straube
Andreas Straube
AMA. May
A. May
PKPeter Kropp
Peter Kropp
ZKZ. Katsarava
Z. Katsarava
GHG. Haag
G. Haag
Stefan EversStefan Evers
Stefan Evers

4 April 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JIJyoti Iyer
Jyoti Iyer
LGLindsey K. Gentry
Lindsey K. Gentry
MBMary Bergwell
Mary Bergwell
ASAmy Smith
Amy Smith
SGSarah Guagliardo
Sarah Guagliardo
KOKevin F. O'Connell
Kevin F. O'Connell
Centrioles are submicron-scale, barrel-shaped organelles typically found in pairs, and play important roles in ciliogenesis and bipolar spindle assembly. In general, successful execution of centriole-dependent processes is highly reliant on the ability of the cell to stringently control centriole number. This in turn is mainly achieved through the precise duplication of centrioles during each S phase. Aberrations in centriole duplication disrupt spindle assembly and cilia-based signaling and have been linked to cancer, primary microcephaly and a variety of growth disorders. Studies aimed at understanding how centriole duplication is controlled have mainly focused on the post-translational regulation of two key components of this pathway: the master regulatory kinase ZYG-1/Plk4 and the scaffold component SAS-6. In contrast, how transcriptional control mechanisms might contribute to this process have not been well explored. Here we show that the chromatin remodeling protein CHD-1 contributes to the regulation of centriole duplication in theC.elegansembryo. Specifically, we find that loss of CHD-1 or inactivation of its ATPase activity can restore embryonic viability and centriole duplication to a strain expressing insufficient ZYG-1 activity. Interestingly, loss of CHD-1 is associated with increases in the levels of two ZYG-1-binding partners: SPD-2, the centriole receptor for ZYG-1 and SAS-6. Finally, we explore transcriptional regulatory networks governing centriole duplication and find that CHD-1 and a second transcription factor, EFL-1/DPL-1 cooperate to down regulate expression of CDK-2, which in turn promotes SAS-6 protein levels. Disruption of this regulatory network results in the overexpression of SAS-6 and the production of extra centrioles.

27 August 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
PKPeter Kropp
Peter Kropp
JWJing Wu
Jing Wu
MRMike Reidy
Mike Reidy
SSSanjay Shrestha
Sanjay Shrestha
KRKyle Rhodehouse
Kyle Rhodehouse
AGAndy Golden
Andy Golden
Multiple Mitochondrial Dysfunctions Syndrome 1 (MMDS1) is a rare, autosomal recessive disorder caused by mutations in theNFU1gene. NFU1 is responsible for delivery of iron-sulfur clusters (ISCs) to recipient proteins which require these metallic cofactors for their function. Pathogenic variants ofNFU1lead to dysfunction of its target proteins within mitochondria. To date, 20NFU1variants have been reported and the unique contributions of each variant to MMDS1 pathogenesis is unknown. Given that over half of MMDS1 individuals are compound heterozygous for differentNFU1variants, it is valuable to investigate individual variants in an isogenic background. In order to understand the shared and unique phenotypes ofNFU1variants, we used CRISPR/Cas9 gene editing to recreate exact patient variants ofNFU1in the orthologous gene,nfu-1(formerlylpd-8), inC.elegans. Five mutantC.elegansalleles focused on the presumptive iron-sulfur cluster interaction domain were generated and analyzed for mitochondrial phenotypes including respiratory dysfunction and oxidative stress. Phenotypes were variable between the mutantnfu-1alleles and generally presented as an allelic series indicating that not all variants have lost complete function. Furthermore, reactive iron within mitochondria was evident in some, but not all,nfu-1mutants indicating that iron dyshomeostasis may contribute to disease pathogenesis in some MMDS1 individuals.

11 May 2020 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
BMBritta Müller
Britta Müller
TDThomas Dresler
Thomas Dresler
CGCharly Gaul
Charly Gaul
TJTim Jürgens
Tim Jürgens
PKPeter Kropp
Peter Kropp
SFStefanie Förderreuther
Stefanie Förderreuther
Background: Headache sufferers in need of professional health care often do not utilize the care available, and factors influencing headache-specific physician consultation are not yet understood. Objectives of this study are (1) to assess self-reported headache-specific physician consultations and (2) to identify headache-related and sociodemographic predictors.Methods: Data of a random sample of the general population in Germany aged ≥14 years were analyzed (N = 2461). A multivariate binary logistic regression was conducted to identify a parsimonious model to predict physician consultation.Results: 50.7% of the participants with headache reported at least one headache-specific physician consultation during lifetime. Of these, 53.6% had seen one, 26.1% two, and 20.3% more than two physicians because of their headaches. The odds of physician consultation increased with the number of headache days per month (HDM) [(reference HDM < 1) HDM 1–3 (OR = 2.29), HDM 4–14 (OR = 2.41), and HDM ≥15 (OR = 4.83)] and increasing Headache Impact Test score (HIT-6) [(reference “no or little impact”) moderate impact (OR = 1.74), substantial impact (OR = 3.01), and severe impact (OR = 5.08)]. Middle-aged participants were more likely to have consulted than younger and older ones [(reference 14–34 years) 35–54 years (OR = 1.90), 55–74 years (OR = 1.96), ≥75 years (OR = 1.02)]. The odds of physician consultation among self-employed subjects were lower than among employed manual workers (OR = 0.48). The living environment (rural versus urban) did not have an influence on the consultation frequency.Conclusion: The results indicate that apart from burden-related factors (headache frequency; headache impact), health care utilization patterns are also influenced by patients’ occupational status and age. Further research is needed to analyze whether the lower consultation rate means that the self-employed have a higher risk of chronification or that they have more effective self-management strategies regarding headache.

19 August 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
FRFlorian Rimmele
Florian Rimmele
JJJosephine Janke
Josephine Janke
PKPeter Kropp
Peter Kropp
AGAnnette Grossmann
Annette Grossmann
THTill Hamann
Till Hamann
TJTim P. Jürgens
Tim P. Jürgens
Background: The care of patients with headache in the emergency department (ED) represents a diagnostic and clinical challenge. Data on the prevalence and characteristics of headache patients in purely neurological EDs are sparse. The aim of the present study is to examine patient profiles with the cardinal symptom of headache in an academic neurological ED, to analyze correlations between headache characteristics and search for differences compared to the interdisciplinary ED.Methods: This retrospective cross-sectional study assessed all patients who presented to the ED of the Department of Neurology at Rostock University Medical Center between November 2013 and November 2016 with the main symptom of headache. Epidemiological, clinical, diagnostic data as well as key data regarding the care structure were recorded. Correlations between headache characteristics and diagnosis at discharge were analyzed and risk profiles were identified using binary logistic regression analysis.Conclusion: This study comprehensively characterized a large collective of patients with the cardinal symptom of headache presenting to a purely neurology emergency department.

1 February 2022 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MGMarcel Gebhardt
Marcel Gebhardt
PKPeter Kropp
Peter Kropp
FHFrank Hoffmann
Frank Hoffmann
Uwe Klaus ZettlUwe Klaus Zettl
Uwe Klaus Zettl
: For decades, the headache was not considered a typical symptom of multiple sclerosis (MS) and was construed as a “red flag” for important differential diagnoses such as cerebral vasculitis. Meanwhile, several studies have demonstrated an increased prevalence of headaches in MS compared to the general population. This is due to the heterogeneity of headache genesis with frequent occurrence of both primary and secondary headaches in MS. On the one hand, MS and migraine are often comorbid. On the other hand, secondary headaches frequently occur, especially in the course of MS relapses. These are often migraine-like headaches caused by inflammation, which can improve as a result of MS-specific therapy. Headaches are particularly common in the early stages of chronic inflammatory CNS disease, where inflammatory activity is the greatest. In addition, headaches can also occur as a side effect of disease-modifying drugs (DMDs). Headache can occur with most DMDs and is most frequently described with interferon-beta therapy. The aim of this work is to present the prevalence of headaches and describe the heterogeneity of possible causes of headaches in MS. In addition, important therapeutic aspects in the treatment of MS patients, in general, will be presented as well as different approaches to the treatment of headaches in MS depending on the etiological classification.